Easing the current burden on glaucoma services

The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension

Voyager DSLT is already available in select markets in the EU and the UK, and reduces the specialised training required with manual selective laser trabeculoplasty

The link between eye health and mental health may be deeper than previously believed

Our top 10 print stories highlight the core content concepts we explored this year

Gauging patient perceptions in an ethnically diverse UK cohort

A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss